Phase 3 Schizophrenia Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are Japanese, male or female, and aged 18 or older at the time of signing the consent form
• People who have been diagnosed with schizophrenia according to a standard diagnostic system called the DSM-5
• People whose condition has been considered clinically stable by the investigating doctor for at least 8 weeks before the screening visit
• People whose schizophrenia symptom scores fall within a certain range (assessed using two rating scales called PANSS and CGI-S) at both the screening and baseline visits (confirm with trial site)
• People whose antipsychotic medication has not changed for at least 6 weeks before screening, aside from small dose adjustments for tolerability

Who may not be able to join:

• People who have been admitted to a psychiatric hospital within the 8 weeks before screening
• People whose psychiatric symptoms did not improve despite trying two or more antipsychotic medications at appropriate doses for at least 4 weeks each, within the year before screening
• People who have previously been treated with a medication called clozapine
• People who are unwilling or unable to follow the trial's rules about which medications and therapies are allowed or prohibited during the study period

Important: Always verify eligibility with the trial site directly before applying.